The role of performance feedback on the self-efficacy performance relationship

We report 3 studies that explore the moderating role of performance feedback on the within-person relationship between self-efficacy and performance. In Study 1, we provided participants with either very little feedback (current trial performance) or a wider range of previous performance markers (baseline performance and current trial performance) before making efficacy judgments. In Study 2, we refined the selfefficacy measure by providing participants with more detailed feedback regarding their past performance. In Study 3, we applied the methodology from Studies 1 and 2 to a task in which negative self-efficacy effects have been prevalent (i.e., golf putting). Results revealed that performance feedback moderated the self-efficacy-performance relationship. When we provided participants with minimal performance feedback, their self-efficacy was negatively related to subsequent performance; when we provided more detailed feedback, self-efficacy was positively related to subsequent performance. Studies 2 and 3 further confirmed these findings. Results across studies confirm that feedback is an important moderator of the self-efficacy-performance relationship, which can shed light on the equivocal findings to date

Vapor sensing properties of a conductive polymer composite containing Nickel particles with nano-scale surface features

This paper presents an unusual conductive polymer composite, produced by Peratech Ltd under the trademark QTC™, which has many vapor sensing applications. Nickel particles are intimately coated by an elastomeric binder such that no percolative conduction can occur. However, the nickel particles are shown to possess spiky nanoscale surface features, which promote conduction by a field-assisted quantum tunneling mechanism. Granular QTC™ can be dispersed into a polymer matrix to produce a vapor sensor. Under exposure to vapor, the polymer swells and the resistance of the composite increases. In this work, granular sensors are subjected to acetone and tetrahydrofuran (THF) vapors. The response for THF shows an increase in resistance of a factor of 108, over a time-scale of a few seconds. This response is larger and faster than many conventional vapor sensing composites. This is a significantly larger response than that obtained historically for the same sensor, suggesting that some degree of sensor aging is desirable. The response and subsequent recovery can be explained by a case II diffusion model, and linked to Hildebrand solubility parameters of the vapor and polymer components

A novel screen-printed multi-component nanocomposite ink with a pressure sensitive electrical resistance functionality

Here, a novel functional ink is described that is composed of multiple nanoscale components and exhibits pronounced touch pressure sensitive electrical properties ideal for applications in switching, sensing and touch sensitive surfaces. The ink can be screen-printed and the as-printed ink displays a large and reproducible touch pressure sensitive electrical resistance and, in contrast to some other composite materials, the resistance changes occur down to the smallest applied pressures. Detailed scanning electron microscopy shows the complex nanoscale structure of the composite that is critical for the electrical behavior. Current-voltage measurements, under static compressive loading, show monotonic non-linear behavior at low compression and ohmic behavior at higher loadings

Women, men and coronary heart disease: a review of the qualitative literature

Aim. This paper presents a review of the qualitative literature which examines the experiences of patients with coronary heart disease. The paper also assesses whether the experiences of both female and male patients are reflected in the literature and summarizes key themes. Background. Understanding patients' experiences of their illness is important for coronary heart disease prevention and education. Qualitative methods are particularly suited to eliciting patients' detailed understandings and perceptions of illness. As much previous research has been 'gender neutral', this review pays particular attention to gender. Methods. Published papers from 60 qualitative studies were identified for the review through searches in MEDLINE, EMBASE, CINAHL, PREMEDLINE, PsychINFO, Social Sciences Citation Index and Web of Science using keywords related to coronary heart disease. Findings. Early qualitative studies of patients with coronary heart disease were conducted almost exclusively with men, and tended to generalize from 'male' experience to 'human' experience. By the late 1990s this pattern had changed, with the majority of studies including women and many being conducted with solely female samples. However, many studies that include both male and female coronary heart disease patients still do not have a specific gender focus. Key themes in the literature include interpreting symptoms and seeking help, belief about coronary 'candidates' and relationships with health professionals. The influence of social roles is important: many female patients have difficulties reconciling family responsibilities and medical advice, while male patients worry about being absent from work. Conclusions. There is a need for studies that compare the experiences of men and women. There is also an urgent need for work that takes masculinity and gender roles into account when exploring the experiences of men with coronary heart disease

CHIMPS: the 13CO/C18O (J = 3 to 2) Heterodyne Inner Milky Way Plane Survey

We present the 13CO/C18O (J = 3 → 2) Heterodyne Inner Milky Way Plane Survey (CHIMPS) which has been carried out using the Heterodyne Array Receiver Program on the 15 m James Clerk Maxwell Telescope (JCMT) in Hawaii. The high-resolution spectral survey currently covers |b| ≤ 0.5° and 28° ≲ l ≲ 46°, with an angular resolution of 15 arcsec in 0.5 km s-1 velocity channels. The spectra have a median rms of ˜0.6 K at this resolution, and for optically thin gas at an excitation temperature of 10 K, this sensitivity corresponds to column densities of NH2 ˜ 3 × 1020 cm-2 and NH2 ˜ 4 × 1021 cm-2 for 13CO and C18O, respectively. The molecular gas that CHIMPS traces is at higher column densities and is also more optically thin than in other publicly available CO surveys due to its rarer isotopologues, and thus more representative of the three-dimensional structure of the clouds. The critical density of the J = 3 → 2 transition of CO is ≳104 cm-3 at temperatures of ≤20 K, and so the higher density gas associated with star formation is well traced. These data complement other existing Galactic plane surveys, especially the JCMT Galactic Plane Survey which has similar spatial resolution and column density sensitivity, and the Herschel infrared Galactic Plane Survey. In this paper, we discuss the observations, data reduction and characteristics of the survey, presenting integrated-emission maps for the region covered. Position-velocity diagrams allow comparison with Galactic structure models of the Milky Way, and while we find good agreement with a particular four-arm model, there are some significant deviations.Peer reviewedFinal Accepted Versio

Spontaneous Coherence and Collective Modes in Double-Layer Quantum Dot Systems

We study the ground state and the collective excitations of parabolically-confined double-layer quantum dot systems in a strong magnetic field. We identify parameter regimes where electrons form maximum density droplet states, quantum-dot analogs of the incompressible states of the bulk integer quantum Hall effect. In these regimes the Hartree-Fock approximation and the time-dependent Hartree-Fock approximations can be used to describe the ground state and collective excitations respectively. We comment on the relationship between edge excitations of dots and edge magneto-plasmon excitations of bulk double-layer systems.Comment: 20 pages (figures included) and also available at http://fangio.magnet.fsu.edu/~jhu/Paper/qdot_cond.ps, replaced to fix figure

Isospin influences on particle emission and critical phenomenon in nuclear dissociation

Features of particle emission and critical point behavior are investigated as functions of the isospin of disassembling sources and temperature at a moderate freeze-out density for medium-size Xe isotopes in the framework of isospin dependent lattice gas model. Multiplicities of emitted light particles, isotopic and isobaric ratios of light particles show the strong dependence on the isospin of the dissociation source, but double ratios of light isotope pairs and the critical temperature determined by the extreme values of some critical observables are insensitive to the isospin of the systems. Values of the power law parameter of cluster mass distribution, mean multiplicity of intermediate mass fragments ($IMF$), information entropy ($H$) and Campi's second moment ($S_2$) also show a minor dependence on the isospin of Xe isotopes at the critical point. In addition, the slopes of the average multiplicites of the neutrons ($N_n$), protons ($N_p$), charged particles ($N_{CP}$), and IMFs ($N_{imf}$), slopes of the largest fragment mass number ($A_{max}$), and the excitation energy per nucleon of the disassembling source ($E^*/A$) to temperature are investigated as well as variances of the distributions of $N_n$, $N_p$, $N_{CP}$, $N_{IMF}$, $A_{max}$ and $E^*/A$. It is found that they can be taken as additional judgements to the critical phenomena.Comment: 9 Pages, 8 figure

A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial

Background Cough can be a debilitating symptom of idiopathic pulmonary fibrosis (IPF) and is difficult to treat. PA101 is a novel formulation of sodium cromoglicate delivered via a high-efficiency eFlow nebuliser that achieves significantly higher drug deposition in the lung compared with the existing formulations. We aimed to test the efficacy and safety of inhaled PA101 in patients with IPF and chronic cough and, to explore the antitussive mechanism of PA101, patients with chronic idiopathic cough (CIC) were also studied. Methods This pilot, proof-of-concept study consisted of a randomised, double-blind, placebo-controlled trial in patients with IPF and chronic cough and a parallel study of similar design in patients with CIC. Participants with IPF and chronic cough recruited from seven centres in the UK and the Netherlands were randomly assigned (1:1, using a computer-generated randomisation schedule) by site staff to receive PA101 (40 mg) or matching placebo three times a day via oral inhalation for 2 weeks, followed by a 2 week washout, and then crossed over to the other arm. Study participants, investigators, study staff, and the sponsor were masked to group assignment until all participants had completed the study. The primary efficacy endpoint was change from baseline in objective daytime cough frequency (from 24 h acoustic recording, Leicester Cough Monitor). The primary efficacy analysis included all participants who received at least one dose of study drug and had at least one post-baseline efficacy measurement. Safety analysis included all those who took at least one dose of study drug. In the second cohort, participants with CIC were randomly assigned in a study across four centres with similar design and endpoints. The study was registered with ClinicalTrials.gov (NCT02412020) and the EU Clinical Trials Register (EudraCT Number 2014-004025-40) and both cohorts are closed to new participants. Findings Between Feb 13, 2015, and Feb 2, 2016, 24 participants with IPF were randomly assigned to treatment groups. 28 participants with CIC were enrolled during the same period and 27 received study treatment. In patients with IPF, PA101 reduced daytime cough frequency by 31·1% at day 14 compared with placebo; daytime cough frequency decreased from a mean 55 (SD 55) coughs per h at baseline to 39 (29) coughs per h at day 14 following treatment with PA101, versus 51 (37) coughs per h at baseline to 52 (40) cough per h following placebo treatment (ratio of least-squares [LS] means 0·67, 95% CI 0·48–0·94, p=0·0241). By contrast, no treatment benefit for PA101 was observed in the CIC cohort; mean reduction of daytime cough frequency at day 14 for PA101 adjusted for placebo was 6·2% (ratio of LS means 1·27, 0·78–2·06, p=0·31). PA101 was well tolerated in both cohorts. The incidence of adverse events was similar between PA101 and placebo treatments, most adverse events were mild in severity, and no severe adverse events or serious adverse events were reported. Interpretation This study suggests that the mechanism of cough in IPF might be disease specific. Inhaled PA101 could be a treatment option for chronic cough in patients with IPF and warrants further investigation